<p>Mads Bolding Rasmussen, MD is a Danish resident physician and reseacher in Otorhinolaryngology with academic experience spanning rhinology, otology, and neurotology. He is currently affiliated with the Department of Otorhinolaryngology, Head and Neck Surgery and Audiology at Rigshospitalet, Copenhagen, where he is engaged in the projects: The ASSIX trial investigating intraglandular treatment with adipose-derived mesenchymal stem cells for xerostomia in Sjögren’s syndrome, and Tapering of biologics in CRSwNP - a national study on tapering of biologic therapy in chronic rhinosinusitis with nasal polyps (CRSwNP), in which he acts as sub-investigator and national coordinator.</p>